Agency for Healthcare Research and Quality, HHS.
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), we announce an Agency for Healthcare Research and Quality Special Emphasis Panel (SEP) meeting on “AHRQ RFA-HS14-010, “Disseminating and Implementing Evidence from Patient-Centered Outcomes Research in Clinical Practice Using Mobile Health Technology (R21).” As with other SEP meetings, this meeting will commence in open session before closing to the public for the duration of the meeting.
November 20-21, 2014 (Open on November 20 from 8:00 a.m. to 8:30 a.m. and closed for the remainder of the meeting).
Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, Maryland 20878.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Anyone wishing to obtain a roster of members, agenda or minutes of the public portions of this meeting should contact: Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone: (301) 427-1554.
Agenda items for this meeting are subject to change as priorities dictate.
End Further Info
Start Supplemental Information
A SEP is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct, on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly scheduled meetings and do not serve for fixed terms or an extended period of time. Rather, they are asked to participate in particular review meetings which require their expertise.
Each SEP meeting will commence in open session before closing to the public for the duration of the meeting, in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the AHRQ RFA-HS14-010, “Disseminating and Implementing Evidence from Patient-Centered Outcomes Research in Clinical Practice Using Mobile Health Technology (R21)” are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
End Supplemental Information
Dated: September 16, 2014.
[FR Doc. 2014-22704 Filed 9-24-14; 8:45 am]
BILLING CODE 4160-90-M